Skip to main content

COMPASS Pathways plc

CMPS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001816590

No open-market purchases or sales by COMPASS Pathways plc insiders were filed in the last 90 days; 224 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; ARK Invest is the only superinvestor holding it.

Q1 2023 vs. Q4 2022

How the institutions holding COMPASS Pathways plc changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of CMPS: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders1113103−5
Shares7.60M3118.18M+584.4K (+7.7%)
Value$61.0M$2.50K$81.3M+$20.3M (+33.2%)

3 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held COMPASS Pathways plc at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to CMPS in Q1 2023
InstitutionSharesValue% of portfolio
Sculptor Capital LP19,200$190.7K0.00%
Commonwealth Equity Services, LLC14,315$142.0K0.00%
Ameritas Advisory Services, LLC369$3.08K0.00%
Farther Finance Advisors, LLC100$9930.00%
Nalls Sherbakoff Group, LLC30$3120.00%
Grey Fox Wealth Advisors, LLC27$2680.00%
Toronto Dominion Bank9$00.00%

Sold out (12)

Institutions that held COMPASS Pathways plc at the end of Q4 2022 and filed for Q1 2023 without it.

Not filed for Q1 2023 yet (3)

Institutions that held COMPASS Pathways plc at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CMPS in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Sargent Bickham Lagudis LLC280$2.25K
Trustcore Financial Services, LLC16$128
CoreCap Advisors, LLC15$120